<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03985514</url>
  </required_header>
  <id_info>
    <org_study_id>App 2018</org_study_id>
    <nct_id>NCT03985514</nct_id>
  </id_info>
  <brief_title>Acute Appendicitis: Active Observation With and Without Antibiotics</brief_title>
  <official_title>Optimized Treatment for Uncomplicated Acute Appendicitis; Active Observation With or Without Antibiotic Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Göteborg University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vastra Gotaland Region</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Göteborg University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates if early provision of antibiotics is a superior treatment compared to
      &quot;traditional wait and see&quot; with regard to symptom relief for suspected acute uncomplicated
      appendicitis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Recent long-term follow up results of antibiotic treatment of acute appendicitis in
      unselected populations indicate that approximately 70-80 % of patients respond to
      antibiotics, while the remaining 20-25% need an operation. Antibiotic treatment was
      associated with significantly fewer severe and non-severe complications compared to surgery.
      Therefore, antibiotic treatment can be regarded as safe and effective initial treatment of
      acute appendicitis based on evidence.

      However, it remains to be evaluated to what extent antibiotic treatment is more effective
      compared to the most conservative application of procedures in the care of patients with
      acute appendicitis. A well- recognized approach in Sweden is watchful waiting at in-hospital
      conditions. A certain number of patients with suspected uncomplicated appendicitis will
      likely recover without any active treatment, but controlled evidence are lacking to what
      extent such recoveries may occur in the short- and long-term perspective.

      The hypothesis is that antibiotic treatment is superior to active observation with regard to
      symptom relief at suspected acute appendicitis in selected patient groups.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 15, 2018</start_date>
  <completion_date type="Anticipated">May 2021</completion_date>
  <primary_completion_date type="Anticipated">May 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Selected patients with assumed uncomplicated acute appendicitis are allocated to groups &quot;Active observation&quot; or &quot;Antibiotic treatment&quot; in a 1:1 ratio.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with no symptom relief</measure>
    <time_frame>48 hours</time_frame>
    <description>No symptom relief and surgery is deemed necessary.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Appendicitis</condition>
  <arm_group>
    <arm_group_label>Antibiotic treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients will receive in-hospital intravenous antibiotics (Piperacillin/Tazobactam, 4 gram x 3), followed by 8-10 days of out-hospital oral antibiotic treatment (Ciprofloxacin 500 mgx2,Flagyl 400 mgx3). Surgery if no symptom relif occur.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clinical observation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients are followed by in-hospital &quot;Active observation&quot; (watchful waiting) according to clinical routine. Patients are observed until either, recovery and dismissal from hospital, or decision for intervention (surgery) is taken.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antibiotic treatment (Piperacillin/Tazobactam, 4 gram x 3), followed by 8-10 days of out-hospital oral antibiotic treatment (Ciprofloxacin 500 mgx2,Flagyl 400 mgx3).</intervention_name>
    <description>Intravenous antibiotic treatment x 3, followed by oral antibiotics for 8-10 Days.</description>
    <arm_group_label>Antibiotic treatment</arm_group_label>
    <other_name>Piperacillin/Tazobactam</other_name>
    <other_name>Ciprofloxacin</other_name>
    <other_name>Flagyl</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Active observation</intervention_name>
    <description>In-hospital observation without antibiotics</description>
    <arm_group_label>Clinical observation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects with suspected appendicitis.

          -  Age&lt;60 years.

          -  C-reactive protein &lt; 60 mg/L.

          -  White blod cell Count (leucocytes) &lt; 13 e9 /L.

        Exclusion criteria:

          -  Pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kent Lundholm, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Göteborg University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lundholm</last_name>
    <phone>+46-313421000</phone>
    <phone_ext>4437</phone_ext>
    <email>kent.lundholm@surgery.gu.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of surgery, Sahlgrenska University Hospital</name>
      <address>
        <city>Göteborg</city>
        <zip>413 45</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kent Lundholm, MD, prof</last_name>
      <phone>46-31-342-1000</phone>
      <phone_ext>4437</phone_ext>
      <email>kent.lundholm@surgery.gu.se</email>
    </contact>
    <investigator>
      <last_name>Kent Lundholm, MD, prof</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>November 9, 2018</study_first_submitted>
  <study_first_submitted_qc>June 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 13, 2019</study_first_posted>
  <last_update_submitted>June 12, 2019</last_update_submitted>
  <last_update_submitted_qc>June 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Appendicitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Ciprofloxacin</mesh_term>
    <mesh_term>Tazobactam</mesh_term>
    <mesh_term>Piperacillin</mesh_term>
    <mesh_term>Metronidazole</mesh_term>
    <mesh_term>Piperacillin, Tazobactam Drug Combination</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

